Dental Medical Device Manufacturer 'DXM' to Relocate to Gwangju

Gwangju City and DXM Sign Agreement for the Development of Gwangju Medical Industry

[Asia Economy Honam Reporting Headquarters Reporter Park Seon-gang] DXM Co., Ltd., a high-quality dental medical device manufacturing company headquartered in Goyang-si, Gyeonggi-do, is planning to relocate its headquarters and production plant to Gwangju Metropolitan City.

On the 10th, Gwangju Metropolitan City announced that Mayor Lee Yong-seop and DXM Co., Ltd. CEO Jeong Du-rak attended and signed a 'Business Agreement for the Development of Gwangju Medical Industry.'

Through this agreement, DXM Co., Ltd. will establish a production plant for its main products in Gwangju, relocate its headquarters, and promote job creation.

Gwangju City will provide various corporate supports such as AI-based production process advancement and technology development to create a future medical industry ecosystem.

Additionally, both parties agreed to cooperate on policies and technology development to help Gwangju's medical industry grow into a high value-added core industry, and to discover and promote specialized workforce training and employment programs in the medical industry sector.

DXM Co., Ltd. is a high-quality dental medical device manufacturer producing light-curing units, oral cameras, and shadowless lamps.

Its main product is a dental mixing tip, holding the only international patent in Korea and the second worldwide. The dental mixing tip is a single-use consumable dental tool that precisely mixes and injects impression material used to take dental impressions, ensuring continuous sales.

DXM aims to increase its share of the global mixing tip market, which is almost monopolized at 95% by the Swiss company Sulzer, to 15% within three years. It plans to establish a production plant at Gwangju Technopark by this month and relocate its headquarters to Gwangju by 2022.

Gwangju City has selected the biomaterial parts industry centered on dentistry as a key industry and has focused on fostering it, establishing core infrastructure such as the 'Dental Material Parts Technology Support Center' and the 'Biomaterial Testing Research Center,' the largest dental cluster in Korea.

Starting with this business agreement with DXM Co., Ltd., Gwangju plans to accelerate corporate expansion through attracting and nurturing promising companies, and to establish a full-cycle support platform for companies from biomaterial industry development to marketing, aiming to leap into a global medici ty by 2030.

Jeong Du-rak, CEO of DXM Co., Ltd., said, "Based on 20 years of medical device development and production experience and technology, we considered Gwangju, the center of AI and biomaterial industry, as the optimal location to overcome the high barriers of the global market and increase product market share." He added, "We will actively cooperate in the development of the medical industry, talent cultivation, and job creation through relocating our headquarters and factory."

Mayor Lee Yong-seop said, "If Gwangju, which has excellent dental industry technology and AI industry, collaborates with DXM Co., Ltd., which has global competitiveness, both organizations will secure sustainable new growth engines." He added, "We will wholeheartedly support and back DXM Co., Ltd. to grow into a mid-sized company and further into a global company after settling in Gwangju."

This content was produced with the assistance of AI translation services.